ADI Launches the Alzheimer’s Disease Atlas
Access the world's first of its kind platform highlighting how countries diagnose, treat and support people living with dementia.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
Highlights from the National Dementia Plan Pan Regional Workshop 2026
Government representatives, dementia associations and WHO experts gathered in London to share progress, tackle challenges and strengthen collaboration on developing and implementing effective National Dementia Plans worldwide.
ADI continues its global activity and advocacy during the month of October
October signaled another busy month for ADI, with our and board members travelling internationally to capitalize on the growing momentum; from Buenos Aires, Brunei Darussalam, Helsinki, Lausanne, Tbilisi, to The Hague.
National Care Policy for Alzheimer’s and Dementia approved after intervention by ADI and Febraz
ADI and ADI Member, Febraz, participated in a public hearing held by the Human Rights Commission at the Brazilian Federal Senate, to debate public policies for the care of people living with dementia
The government of the Netherlands hosts ‘Defeating dementia’ conference
The resulting declaration includes an essential call for Member States of the WHO to extend the Global Action Plan on dementia to 2035
World Alzheimer’s Month 2023: tangible steps to risk reduction
As World Alzheimer’s Month comes to a close, we reflect on some of the highlights from this year’s campaign
ADI welcomes its newest associations to the Membership Development Programme
Each year, ADI hosts its Alzheimer University for emerging associations, aiming to equip new associations with the skills and knowledge needed to run a successful Alzheimer or dementia association.
ADI attends the Alzheimer’s Association International Conference
The annual event brings together basic scientists, clinical researchers, early career investigators, clinicians and the care research community to discuss the latest developments and innovation in Alzheimer’s and dementia research.
FDA converts lecanemab to traditional approval
Lecanemab represents the first antibody treatment for Alzheimer’s disease to have received traditional approval from the Food and Drug Administration in the US.
Princess Muna of Jordan becomes global ambassador for ADI
Her Royal Highness Princess Muna Al Hussein is the fourth global Ambassador of ADI, joining Queen Silvia of Sweden, Queen Sofia of Spain and the Luis Guillermo Solís Rivera, former President of Costa Rica.